Studied in people
There are published studies in people. It is not a licensed medicine in the United States or the European Union.
This page is a stub
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
How strong is the evidence
How far it has climbed
Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.
- Licensed medicine
A regulator has reviewed the trials and licensed it for a named use.
- Phase 3
Large randomized trials, often thousands of people, against placebo or a standard treatment.
- Phase 2
Mid-sized trials that measure dose against effect in people with the condition.
- Phase 1 and early human studies: LL-37
First studies in people: safety, and how the body handles it.
- Cells and animals
Laboratory and animal work. An animal result is not a result in people.
- 2,555
- papers on PubMed
- 1,844
- of them in people
- 38
- randomized trials
- 266
- reviews
A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16
Handling and reconstitution
From powder to a measured sample
The same four steps for any lyophilized vial. Laboratory handling, not use in a person.
1. Read the vial
The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.
2. Add the diluent
A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.
3. Work out the strength
Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.
4. Measure the sample
Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.
The calculator below does the arithmetic and shows its working.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on LL-37 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of LL-37; no amount here is a recommendation.
LL-37: on PubMed
What PubMed held for LL-37 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 2,555
- papers
- 1,844
- in humans
- 60
- clinical trials
- 38
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
TrialNakatsuji T, Chen TH, Narala S, et al. Science translational medicine, 2017. PMID 28228596
- The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12(®) in infant colic: A randomised, double blind, placebo-controlled trial
Randomized trialNocerino R, De Filippis F, Cecere G, et al. Alimentary pharmacology & therapeutics, 2020. PMID 31797399
- Acute salivary antimicrobial peptide secretion response to different exercise intensities and durations
Randomized trialIto R, Uchino T, Uchida M, et al. American journal of physiology. Regulatory, integrative and comparative physiology, 2024. PMID 39155711
- Niacinamide leave-on formulation provides long-lasting protection against bacteria in vivo
TrialMathapathi MS, Mallemalla P, Vora S, et al. Experimental dermatology, 2017. PMID 28094872
- Cationic antimicrobial peptides and periodontal physiopathology: A systematic review
ReviewJourdain ML, Velard F, Pierrard L, et al. Journal of periodontal research, 2019. PMID 31215656
- Diagnostic value of anti-microbial peptide, cathelicidin in congenital pneumonia
TrialGad GI, Abushady NM, Fathi MS, et al. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2015. PMID 25354286
- LL-37: A Direct Link Between Inflammation and Myocardial Infarction
StudySchneider DJ JACC. Basic to translational science, 2024. PMID 39170953
- Role of LL-37 in thrombotic complications in patients with COVID-19
StudyDuan Z, Zhang J, Chen X, et al. Cellular and molecular life sciences : CMLS, 2022. PMID 35596804
Search used: ("LL-37"[tiab]). Run it on PubMed
Research links
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for LL-37 on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.